Saturday, July 11, 2026

pharma · Helicobacter Pylori · Type 2 Diabetes

Shandong Jinpharm Co.,Ltd

Shandong Jinpharm Co.,Ltd clinical programs — 3 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Linyi, CN HQ
5 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Linyi, CN
Employees
5
Programs
3
Drugs
5
Patents
0
Intelligence · Clinical Programs

Shandong Jinpharm Co.,Ltd projects

3 ClinicalTrials.gov programs sponsored by Shandong Jinpharm Co.,Ltd.

Shandong Jinpharm Co.,Ltd has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. MSC

    Shandong University

    Type 2 Diabetes

    phase 2 mab active

    1 trial
  2. placebo

    Shandong University

    Sedation

    approved small molecule active

    1 trial
  3. bismuth-containing quadral therapy based on antibiotic susceptibility

    Shandong University

    Helicobacter Pylori

    small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Shandong Jinpharm Co.,Ltd have?

3 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.